PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.86%
Revenue growth above 1.5x MRVL's 5.85%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
14.93%
Gross profit growth above 1.5x MRVL's 6.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
5.56%
EBIT growth 75-90% of MRVL's 7.21%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
5.56%
Operating income growth at 75-90% of MRVL's 7.21%. Bill Ackman would demand a plan to enhance operating leverage.
6.35%
Net income growth at 50-75% of MRVL's 9.50%. Martin Whitman would question fundamental disadvantages in expenses or demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.65%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-5.51%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-197.06%
Negative OCF growth while MRVL is at 38.66%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-711.11%
Negative FCF growth while MRVL is at 93.90%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
46.78%
AR growth well above MRVL's 26.90%. Michael Burry fears inflated revenue or higher default risk in the near future.
-44.74%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
6.08%
Asset growth above 1.5x MRVL's 2.81%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.80%
BV/share growth above 1.5x MRVL's 1.08%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-34.09%
We’re deleveraging while MRVL stands at 5.86%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
22.73%
R&D growth drastically higher vs. MRVL's 2.23%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.96%
SG&A growth well above MRVL's 3.43%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.